Subscribe

The briefing lists what changed since the previous snapshot: FDA notices and recalls, drug-safety signals that are new or stronger, trials, and PubMed titles.

• A confirmation email comes first. The address is added only after that link is opened.
• Each sent issue has a signed unsubscribe link. It takes effect immediately.
• Past issues stay on the site. Read the archive.